- Home
- EDIT vs AMSF Comparison
EDIT vs AMSF Comparison
Compare EDIT & AMSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EDIT | AMSF |
|---|---|---|
| Founded | 2013 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Accident &Health Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 526.4M | 584.3M |
| IPO Year | 2016 | 1996 |
Fundamental Metrics
Financial Performance| Metric | EDIT | AMSF |
|---|---|---|
| Price | $2.82 | $30.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $5.30 | ★ $46.33 |
| AVG Volume (30 Days) | ★ 2.7M | 186.6K |
| Earning Date | 05-11-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 8.61% |
| EPS Growth | ★ 37.50 | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | $31,937,000.00 | ★ $317,252,000.00 |
| Revenue This Year | N/A | $8.45 |
| Revenue Next Year | N/A | $6.03 |
| P/E Ratio | ★ N/A | $70.79 |
| Revenue Growth | ★ 132.64 | 2.66 |
| 52 Week Low | $1.66 | $29.42 |
| 52 Week High | $4.54 | $47.86 |
Technical Indicators
Market Signals| Indicator | EDIT | AMSF |
|---|---|---|
| Relative Strength Index (RSI) | 46.74 | 46.69 |
| Support Level | $2.77 | $29.44 |
| Resistance Level | $3.27 | $31.74 |
| Average True Range (ATR) | 0.31 | 0.68 |
| MACD | 0.04 | 0.07 |
| Stochastic Oscillator | 29.08 | 51.53 |
Price Performance
Historical ComparisonAbout EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.
About AMSF AMERISAFE Inc.
AMERISAFE Inc is a specialty provider of workers' compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, agriculture, manufacturing, maritime, and telecommunications. The company generates a majority of its revenue in the form of premiums. The Company operates as a single reportable segment, Insurance Operations.